Related references
Note: Only part of the references are listed.Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
Paul Roepman et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
SMAD2, SMAD3 and SMAD4 Mutations in Colorectal Cancer
Nicholas I. Fleming et al.
CANCER RESEARCH (2013)
An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Lauren Averett Byers et al.
CLINICAL CANCER RESEARCH (2013)
TGF-beta signaling and epithelial-mesenchymal transition in cancer progression
Yoko Katsuno et al.
CURRENT OPINION IN ONCOLOGY (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Coordinate Transcriptional and Translational Repression of p53 by TGF-β1 Impairs the Stress Response
Fernando J. Lopez-Diaz et al.
MOLECULAR CELL (2013)
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
Felipe De Sousa E Melo et al.
NATURE MEDICINE (2013)
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Alexandre Calon et al.
CANCER CELL (2012)
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang et al.
CELL (2012)
Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
Cristina Oliveras-Ferraros et al.
CELL CYCLE (2012)
Epithelial-Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines
Hui Zhao et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Autocrine TGF-beta protects breast cancer cells from apoptosis through reduction of BH3-only protein, Bim
Yukari Hoshino et al.
JOURNAL OF BIOCHEMISTRY (2011)
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramon Salazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma
Hidetaka Uramoto et al.
LUNG CANCER (2011)
Taming the dragon: genomic biomarkers to individualize the treatment of cancer
Ian J. Majewski et al.
NATURE MEDICINE (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
TGF-beta 1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer
Shinako Araki et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
Joseph H. Taube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
Zhan Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition
Carl-Henrik Heldin et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
A. Emre Sayan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Chad J. Creighton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
TGFβ-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2
Sneha Ramesh et al.
EMBO REPORTS (2008)
Transforming growth factor-β requires its target plasminogen activator inhibitor-1 for cytostatic activity
Roderik M. Kortlever et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer
Karsten Gravdal et al.
CLINICAL CANCER RESEARCH (2007)
Upregulation of Twist-1 by NF-κB blocks cytotoxicity induced by chemotherapeutic drugs
Can G. Pham et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma
Barbara A. Frederick et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Inhibition of transforming growth factor-β1 signaling attenuates ataxia telanglectasia mutated activity in response to genotoxic stress
Julia Kirshner et al.
CANCER RESEARCH (2006)
Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition
Sylvie Thuault et al.
JOURNAL OF CELL BIOLOGY (2006)
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines
Anthony D. Yang et al.
CLINICAL CANCER RESEARCH (2006)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients
RL Yauch et al.
CLINICAL CANCER RESEARCH (2005)
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition
S Thomson et al.
CANCER RESEARCH (2005)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Regulation of the polarity protein Par6 by TGFβ receptors controls epithelial cell plasticity
B Ozdamar et al.
SCIENCE (2005)
TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia
NA Bhowmick et al.
SCIENCE (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
